Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Mirae Asset Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.12.44032004418344.6998
Domestic EquitiesDivi's Laboratories Ltd.8.5749371682237.5977
Domestic EquitiesGlenmark Pharmaceuticals Ltd.6.9120941043191.5211
Domestic EquitiesApollo Hospitals Enterprise Ltd.5.7961228046160.6014
Domestic EquitiesCipla Ltd.5.55291018081153.8626
Domestic EquitiesLupin Ltd.5.2278686670144.8530
Domestic EquitiesDr. Reddy's Laboratories Ltd.4.3429946480120.3355
Domestic EquitiesAurobindo Pharma Ltd.4.2372992443117.4060
Domestic EquitiesFortis Healthcare Ltd.4.22111323084116.9606
Domestic EquitiesIPCA Laboratories Ltd.3.459267551895.8492
Domestic EquitiesLaurus Labs Ltd.3.322083074892.0469
Domestic EquitiesAlkem Laboratories Ltd.3.247216339689.9740
Domestic EquitiesAster DM Healthcare Ltd.3.2249144859389.3565
Domestic EquitiesKrishna Institute of Medical Sciences Ltd.3.1743144518687.9540
Domestic EquitiesJB Chemicals & Pharmaceuticals Ltd.3.098847184885.8622
Domestic EquitiesEris Lifesciences Ltd.3.081156702485.3711
Domestic EquitiesTorrent Pharmaceuticals Ltd.2.997321571683.0507
Domestic EquitiesOnesource Specialty Pharma Ltd.2.932844882381.2639
Domestic EquitiesSai Life Sciences Ltd.2.692882136174.6124
Domestic EquitiesMankind Pharma Ltd.1.910024094152.9227
Domestic EquitiesGland Pharma Ltd.1.812229160350.2140
Domestic EquitiesAnthem Biosciences Ltd.1.237552631834.2896
Domestic EquitiesCohance Lifesciences Ltd.0.988051791727.3771
Domestic EquitiesRubicon Research Ltd.0.915937278025.3770
Domestic EquitiesDeepak Nitrite Ltd.0.776012417021.5025
Domestic EquitiesDr. Lal Path labs Ltd.0.621911622017.2308
Domestic EquitiesSagility Ltd.0.5932315952016.4358
Domestic EquitiesCorona Remedies Ltd.0.584611697016.1992
Domestic EquitiesSyngene International Ltd.0.533822718114.7895
Domestic EquitiesSudeep Pharma Ltd.0.445720490012.3503
Domestic EquitiesNeogen Chemicals Ltd.0.440010296112.1926
Domestic EquitiesWockhardt Ltd.0.0544104261.5078
Domestic EquitiesBiocon Ltd.0.007150010.1970
Total 99.4560 2755.7645
Cash & Cash Equivalents and Net AssetsTREPS0.6809 18.8667
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.1454 -4.0284
Total 0.5355 14.8383
Domestic Mutual Funds UnitsMirae Asset Liquid Fund-Direct Plan-Growth0.00848150.2338
Total 0.0084 0.2338
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.